Navigation Links
Eurofins MWG Operon and Genomatix launch strategic alliance
Date:7/8/2010

Eurofins MWG Operon, an expert in next generation sequencing (NGS) and Genomatix Software GmbH, a leading company in complex analysis and interpretation of such NGS data, announce their decision to combine their expertise and join forces to offer state-of-the art solutions for comprehensive genome analysis and re-sequencing project services.

"We are pleased to cooperate with a partner offering such a high level of expertise in understanding and interpretation of complex biological processes. The special know-how of Genomatix with its rich proprietary data background will have an enormous impact on our service offerings to our customers and will add a further layer of quality to strengthen our position as the leading provider for next generation sequencing services" says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services.

Klaus May, Chief Business Officer of Genomatix, says: "Eurofins MWG Operon is an outstanding quality and service oriented company with friendly, bright and competent people. I am highly satisfied about this partnership, which represents the first one-stop-shop for complete project services, from experimental planning, wet-lab work and data analysis, to data interpretation and deep biological understanding. Together, we offer our customers cutting edge science and technology without the need for them to make major investments in equipment, infrastructure and manpower."

Both partners have already successfully worked together to gain several significant projects where applicative know-how and powerful bioinformatic capabilities have been key for effective project consulting and execution.


'/>"/>

Contact: Dr. Martin Seifert
seifert@genomatix.de
49-895-997-660
Genomatix Software GmbH
Source:Eurekalert

Page: 1

Related biology news :

1. Verizon Business to Provide Global IP for Eurofins Scientific
2. Genomatix gives a hand in the analysis of Wayne States sequencing projects
3. University of Michigan installs second Genomatix Genome Analyzer
4. MCTP bought Genomatix NextGen Sequencing analysis stations
5. Genomatix gets patent for comparative genomics method
6. CRG buys Genomatix Next Generation Sequencing analysis solution
7. Boehringer Ingelheim uses Genomatix Next Generation Sequencing data analysis systems
8. Genomatix joins Illumina-Connect program
9. Announcing launch of FRAX version 3.1
10. Ten years on, Wellcome Trust launches study of 10,000 human genomes in UK
11. American Sociological Association launches first-of-its-kind teaching tool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... MOINES, Iowa , Jan. 11, 2017 ... industry first with the release of its patent-pending calibration ... quickly and reliably perform calibrations, securely upload data logs ... flexibility for the customer. "Fighting drunk driving ... only for the public at large, but also for ...
(Date:1/6/2017)... 2017  SomaLogic announced today that it has ... by iCarbonX, the China -based ... Digital Health Ecosystem that can define each person,s ... biological, behavioral and psychological data, the Internet and ... SomaLogic will provide proteomics data and applications expertise ...
(Date:1/4/2017)... VEGAS , Jan. 4, 2017  CES ... performance biometric sensor technology, today announced the launch ... sensor systems, the highly-accurate biometric sensor modules ... biometric technology, experience and expertise. The two ... Benchmark designed specifically for hearables, and Benchmark BW2.0, ...
Breaking Biology News(10 mins):
(Date:1/21/2017)...   Boston Biomedical , an industry leader in ... stemness pathways, today presented data from two clinical studies ... American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium ... In a Phase Ib/II study of napabucasin – ... stemness pathways by targeting STAT3 – colorectal cancer (CRC) ...
(Date:1/20/2017)... Stock-Callers.com explores the Biotech industry ... most recent performances of select equities. In this morning,s ... ), Abeona Therapeutics Inc. (NASDAQ: ABEO ), ... Sage Therapeutics Inc. (NASDAQ: SAGE ). According ... global Biotech market size is expected to reach $604.40 billion by 2020 due ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... Health Organization, cancer is one of leading causes of ... in 2012. Although the number of cancer related deaths ... since 1990. Rising in incidence rate of various cancers ... According to a research report by Global Market Insights, ...
(Date:1/19/2017)... Research and Markets has announced the addition of the ... Global Opportunity Analysis and Industry Forecast, 2014-2022" report to their ... Cancer ... reach $15,737 million by 2022 from $6,521 in 2015, growing at ... Omic technologies segment accounted for more than half of the revenue ...
Breaking Biology Technology: